无码欧美成人av天堂456软件,大胆日本熟妇XXXX,9277在线观看免费播放,4p三个男人让我爽了一夜

技術(shù)外包服務(wù):

★磷酸化細胞核因子抗體費用 分子生物學：質(zhì)粒抽提、PCR、Q-PCR、RT-PCR、分子生物學：基因合成、引物合成、基因測序、載體構(gòu)建等

★蛋白工程：原核、哺乳動物蛋白表達系統(tǒng)等

★病毒包裝：腺病毒、慢病毒等

★抗體工程：磁珠分選、病理染色、WB、ELISA、IP、IF、IHC、FACS、Confocal等等

★細胞工程：細胞表型分析(凋亡、增殖、周期、遷移、侵襲、修復、克隆形成)、細胞培養(yǎng)、細胞膜制備、穩(wěn)定細胞株構(gòu)建、細胞RNAi技術(shù)等等。

實驗流程：

磷酸化細胞核因子抗體費用 英文名稱  Anti-phospho-NFKB p65(Ser536)

中文名稱  磷酸化細胞核因子抗體費用 

別    名 NF-κB p65(Phospho-Ser536); RELA(phospho S536); NFKBp65; NF-κBp65; p65 NF kappaB; p65 NFkB; NFKBp65; RELA; Transcription Factor p65; v rel avian reticuloendotheliosis viral oncogene homolog A (nuclear factor of kappa light polypeptide gene enhancer in B cells 3 (p65)); V Rel Avian Reticuloendotheliosis Viral Oncogene Homolog A; v rel reticuloendotheliosis viral oncogene homolog A (avian); v-rel reticuloendotheliosis viral oncogene homolog A; p65NFKB; Avian reticuloendotheliosis viral (v rel) oncogene homolog A; MGC131774; NFKB 3; NFKB3; Nuclear Factor NF Kappa B p65 Subunit; Nuclear factor of kappa light polypeptide gene enhancer in B cells 3; Nuclear Factor Of Kappa Light Polypeptide Gene Enhancer In B Cells.

產(chǎn)品屬性：

濃    度  1mg/1ml

規(guī) 格  0.1ml/100μg

抗體來源  Rabbit

克隆類型   polyclonal

交叉反應   Human, Mouse, Rat, Chicken, Dog, Cow, Horse

產(chǎn)品類型   一抗 磷酸化抗體  

研究領(lǐng)域     染色質(zhì)和核信號 信號轉(zhuǎn)導 轉(zhuǎn)錄調(diào)節(jié)因子 激酶和磷酸酶

蛋白分子量  predicted molecular weight: 61kDa 

性    狀   Lyophilized or Liquid

免 疫 原  KLH conjugated Synthesised phosphopeptide derived from human NFKBp65 around the phosphorylation site of(Ser536)

亞    型  IgG

純化方法   affinity purified by Protein A

儲 存 液   0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide

磷酸化細胞核因子抗體費用 產(chǎn)品應用   WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復） 

 not yet tested in other applications.

 optimal dilutions/concentrations should be determined by the end user.  

保存條件  Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. 

Important Note  This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. 

產(chǎn)品介紹 NF-kappa-B is a ubiquitous transcription factor involved in several biological processes. It is held in the cytoplasm in an inactive state by specific inhibitors. Upon degradation of the inhibitor, NF-kappa-B moves to the nucleus and activates transcription of specific genes. NF-kappa-B is composed of NFKB1 or NFKB2 bound to either REL, RELA, or RELB. The most abundant form of NF-kappa-B is NFKB1 complexed with the product of this gene, RELA. Four transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011].

Function : NF-kappa-B is a pleiotropic transcription factor present in almost all cell types and is the endpoint of a series of signal transduction events that are initiated by a vast array of stimuli related to many biological processes such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52 and the heterodimeric p65-p50 complex appears to be most abundant one. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric p65-p50 and p65-c-Rel complexes are transcriptional activators. The NF-kappa-B p65-p65 complex appears to be involved in invasin-mediated activation of IL-8 expression. The inhibitory effect of I-kappa-B upon NF-kappa-B the cytoplasm is exerted primarily through the interaction with p65. p65 shows a weak DNA-binding site which could contribute directly to DNA binding in the NF-kappa-B complex. Associates with chromatin at the NF-kappa-B promoter region via association with DDX1.Subunit : Component of the NF-kappa-B p65-p50 complex. Component of the NF-kappa-B p65-c-Rel complex. Homodimer; component of the NF-kappa-B p65-p65 complex. Component of the NF-kappa-B p65-p52 complex. May interact with ETHE1. Binds AES and TLE1. Interacts with TP53BP2. Binds to and is phosphorylated by the activated form of either RPS6KA4 or RPS6KA5. Interacts with ING4 and this interaction may be indirect. Interacts with CARM1, USP48 and UNC5CL. Interacts with IRAK1BP1 (By similarity). Interacts with NFKBID (By similarity). Interacts with NFKBIA. Interacts with GSK3B. Interacts with NFKBIB (By similarity). Interacts with NFKBIE. Interacts with NFKBIZ. Interacts with EHMT1 (via ANK repeats) (By similarity). Part of a 70-90 kDa complex at least consisting of CHUK, IKBKB, NFKBIA, RELA, IKBKAP and MAP3K14. Interacts with HDAC3; HDAC3 mediates the deacetylation of RELA. Interacts with HDAC1; the interaction requires non-phosphorylated RELA. Interacts with CBP; the interaction requires phosphorylated RELA. Interacts (phosphorylated at 'Thr-254') with PIN1; the interaction inhibits p65 binding to NFKBIA. Interacts with SOCS1. Interacts with UXT. Interacts with MTDH and PHF11. Interacts with ARRB2. Interacts with human respiratory syncytial virus (HRSV) protein M2-1. Interacts with NFKBIA (when phosphorylated), the interaction is direct; phosphorylated NFKBIA is part of a SCF(BTRC)-like complex lacking CUL1. Interacts with RNF25. Interacts (via C-terminus) with DDX1. Interacts with UFL1 and COMMD1. Interacts with BRMS1; this promotes deacetylation of 'Lys-310'. Interacts with NOTCH2 (By similarity). Directly interacts with MEN1; this interaction represses NFKB-mediated transactivation. Interacts with AKIP1, which promotes the phosphorylation and nuclear retention of RELA. Interacts (via the RHD) with GFI1; the interaction, after bacterial lipopolysaccharide (LPS) stimulation, inhibits the transcriptional activity by interfering with the DNA-binding activity to target gene promoter DNA.Subcellular Location : Nucleus. Cytoplasm. Note=Colocalized with DDX1 in the nucleus upon TNF-alpha induction. Nuclear, but also found in the cytoplasm in an inactive form complexed to an inhibitor (I-kappa-B). Colocalizes with GFI1 in the nucleus after LPS stimulation.Post-translational modifications : Ubiquitinated, leading to its proteasomal degradation. Degradation is required for termination of NF-kappa-B response.Monomethylated at Lys-310 by SETD6. Monomethylation at Lys-310 is recognized by the ANK repeats of EHMT1 and promotes the formation of repressed chromatin at target genes, leading to down-regulation of NF-kappa-B transcription factor activity. Phosphorylation at Ser-311 disrupts the interaction with EHMT1 without preventing monomethylation at Lys-310 and relieves the repression of target genes.Phosphorylation at Ser-311 disrupts the interaction with EHMT1 and promotes transcription factor activity. Phosphorylation on Ser-536 stimulates acetylation on Lys-310 and interaction with CBP; the phosphorylated and acetylated forms show enhanced transcriptional activity. Phosphorylation at Ser-276 by RPS6KA4 and RPS6KA5 promotes its transactivation and transcriptional activities.Reversibly acetylated; the acetylation seems to be mediated by CBP, the deacetylation by HDAC3 and SIRT2. Acetylation at Lys-122 enhances DNA binding and impairs association with NFKBIA. Acetylation at Lys-310 is required for full transcriptional activity in the absence of effects on DNA binding and NFKBIA association. Acetylation can also lower DNA-binding and results in nuclear export. Interaction with BRMS1 promotes deacetylation of Lys-310. Lys-310 is deacetylated by SIRT2.S-nitrosylation of Cys-38 inactivates the enzyme activity.Sulfhydration at Cys-38 mediates the anti-apoptotic activity by promoting the interaction with RPS3 and activating the transcription factor activity.Sumoylation by PIAS3 negatively regulates DNA-bound activated NF-kappa-B.Similarity : Contains 1 RHD (Rel-like) domain.Database links : UniProtKB/Swiss-Prot: Q04206.2轉(zhuǎn)錄調(diào)節(jié)因子（Transcriptin Regulators）NF-κBp65是一種重要的轉(zhuǎn)錄因子，NF-kBp65可激活參與、細胞增殖、細胞凋亡等基因的調(diào)節(jié)，影響著細胞的凋亡，同時影響著細胞對細胞毒性藥物及離子輻射的敏感性。ras基因誘導的致癌突變作用需NFkB的活化，提示NFkB在致癌發(fā)生方面可能起一定作用；另有文獻報道，在、非小細胞性、、T或B淋巴細胞及誘變導致的等人類中，NFkB活化或表達。NF-кB可以保護細胞免受以及電離輻射等引起的凋亡作用，而抑制NFkB的表達可以增加TNF等引起的細胞凋亡，以及增加及對細胞的敏感性。

全、新、優(yōu)、品、好四大特點：

磷酸化細胞核因子抗體費用 全：公司提供上萬種產(chǎn)品，涵蓋了生物試劑，elisa試劑盒，標準品，培養(yǎng)基，原裝耗材，抗體、培養(yǎng)基、ATCC細胞等，基本上各種科研所需產(chǎn)品在我司都能找到。

新：產(chǎn)品更新速度較快，基本上每周都有新產(chǎn)品出現(xiàn)。

優(yōu)：產(chǎn)品質(zhì)量好，投訴比較少。

好：我公司具有優(yōu)質(zhì)的技術(shù)團隊，產(chǎn)品一旦售出，實驗過程中遇到困難可提供在線技術(shù)咨詢。使您使用產(chǎn)品時沒有任何的后顧之憂。

正在熱銷的相關(guān)產(chǎn)品：

PF-3(Human platelet factor 3) ELISA Kit 人血小板因子3Multi-class antibodies規(guī)格： 48T

Anti-LMP2 低分子質(zhì)量蛋白2抗體Multi-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh HCF2/Heparin Cofactor II 肝素輔助因子II抗體 規(guī)格 0.2ml

i-PTH(Mouse intact Parathormone) ELISA Kit 小鼠全段甲狀旁腺素 96T

PDGF-A 英文名稱： 血小板源性生長因子A抗體 0.1ml

phospho-BMX (Tyr566) 英文名稱： 磷酸化非受體性蛋白酪酸激酶ETK抗體 0.1ml

Anti-LMP2 低分子質(zhì)量蛋白2抗體Multi-class antibodies規(guī)格： 0.2ml

ATGA/TGAB ELISA Kit 大鼠抗甲狀腺球蛋白抗體Multi-class antibodies規(guī)格： 48T

Anti-Acetyl CoA Carboxylase/FITC 熒光素標記兔抗人、大、小鼠、猴、乙酰輔酶A羧化酶抗體IgGMulti-class antibodies規(guī)格： 0.2ml

Rhesus antibody Rh FIBCD1 含纖維蛋白原C結(jié)構(gòu)域蛋白1抗體 規(guī)格 0.2ml

NGF- Beta(Human Nerve growth factor- Beta) ELISA kit 人的神經(jīng)生長因子-β 96T

Mtp53(N235K N239Y) 英文名稱： 突變型P53抗體 0.1ml

API5 英文名稱： 凋亡抑制因子5抗體 0.1ml

Anti-Acetyl CoA Carboxylase/FITC 熒光素標記兔抗人、大、小鼠、猴、乙酰輔酶A羧化酶抗體IgGMulti-class antibodies規(guī)格： 0.2ml

PP(Human Pepsin) ELISA Kit 人胃蛋白酶Multi-class antibodies規(guī)格： 48T

Anti-N-Ras 原癌基因抗體Multi-class antibodies規(guī)格： 0.1ml

Rhesus antibody Rh IGF1R/CD221 樣生長因子I受體抗體 規(guī)格 0.1ml

LKM(Human liver kidney microsome autoantibody) ELISA Kit 人抗肝腎微粒體抗體 96T

PP1A 英文名稱： 蛋酸酶2Cα抗體 0.1ml

c-Abl 英文名稱： 非受體酪酸激酶c-Abl抗體 0.1ml

Anti-N-Ras 原癌基因抗體Multi-class antibodies規(guī)格： 0.1ml

葡萄糖酪胨瓊脂250g用于食品中臘樣芽孢桿菌鑒定和計數(shù)(APHA方法)

LB營養(yǎng)瓊脂 LB Nutrient Agar 用于分子生物學中大腸桿菌的培養(yǎng)

營養(yǎng)瓊脂(NA) Nutrient Agar 250 細菌總數(shù)測定，細菌傳代培養(yǎng)

RS瓊脂250g/瓶用于致病性嗜水氣單胞菌的分離incubationmediaRS瓊脂250g/瓶用于致病性嗜水氣單胞菌的分離

mTSB肉湯 250g 用于0157選擇性增菌(ISO方法)

SabouraudDextroseAgarMedium

煌綠肉湯增菌液基礎(chǔ) 250(g) incubation media 煌綠肉湯增菌液基礎(chǔ) 250(g)

1% NaC1阿拉伯糖發(fā)酵管 1% NaC1阿拉伯糖發(fā)酵管 20支 BR

HC瓊脂基礎(chǔ)250用于化妝品中霉菌總數(shù)測定(Acumedia方法)incubationmediaHC瓊脂基礎(chǔ)250用于化妝品中霉菌總數(shù)測定(Acumedia方法)

Bolton肉湯 250g 用于空腸彎曲菌的增菌(GB標準)

磷酸化細胞核因子抗體費用 胰酪胨大豆酵母浸膏瓊脂(TSA-YE) 250(g)  incubation media 胰酪胨大豆酵母浸膏瓊脂(TSA-YE) 250(g)

李氏菌選擇性培養(yǎng)基基礎(chǔ)(MMA) 250(g)  incubation media 李氏菌選擇性培養(yǎng)基基礎(chǔ)(MMA) 250(g)

糖發(fā)酵肉湯基礎(chǔ) 250(g)  incubation media 糖發(fā)酵肉湯基礎(chǔ) 250(g)

李氏菌增菌肉湯(LB1，LB2)基礎(chǔ) 250(g)  incubation media 李氏菌增菌肉湯(LB1，LB2)基礎(chǔ) 250(g)